2Y03
TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND BOUND AGONIST ISOPRENALINE
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE ID23-2 |
Synchrotron site | ESRF |
Beamline | ID23-2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2009-06-26 |
Detector | MARRESEARCH |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 89.700, 61.600, 101.600 |
Unit cell angles | 90.00, 109.70, 90.00 |
Refinement procedure
Resolution | 95.690 - 2.850 |
R-factor | 0.22166 |
Rwork | 0.220 |
R-free | 0.25353 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2vt4 |
RMSD bond length | 0.014 |
RMSD bond angle | 1.516 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | REFMAC (5.5.0109) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 42.250 | 3.000 |
High resolution limit [Å] | 2.850 | 2.850 |
Rmerge | 0.120 | 0.580 |
Number of reflections | 24016 | |
<I/σ(I)> | 7 | 1.8 |
Completeness [%] | 97.5 | 97 |
Redundancy | 2.7 | 2.5 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 8.5 | 277 | SITTING DROP VAPOUR DIFFUSION, PROTEIN (15MG/ML) IN 100MM NACL, 0.1MM EDTA, 1.0MM (R)-ISOPRENALINE, 0.45MG/ML CHS, 0.5% HEGA-10, 0.1M TRIS-HCL PH8.5, 28% PEG600 AT 4 DEGREES C |